Enzo BioChem reduces loses in 1st quarter
Enzo BioChem Inc.,Manhattan
Biochemical research and development
First quarter: Ended Oct. 31
Net income: Loss of $1.1 million, compared with loss of $1.9 million in the same period last year
Revenue: $25.7 million, compared with $25.2 million a year ago
Charges: $1.8 million inventory and severance
Company statement: The company, which has a major division, Enzo Clinical Labs, based in Farmingdale, said, "We are pleased to report that our program instituted this quarter aimed at making Enzo more efficient and designed to produce more effective use of our assets is beginning to show results, as demonstrated by improved performance."
Out East with Doug Geed: Wine harvests, a fish market, baked treats and poinsettias NewsdayTV's Doug Geed visits two wineries and a fish market, and then it's time for holiday cheer, with a visit to a bakery and poinsettia greenhouses.
Out East with Doug Geed: Wine harvests, a fish market, baked treats and poinsettias NewsdayTV's Doug Geed visits two wineries and a fish market, and then it's time for holiday cheer, with a visit to a bakery and poinsettia greenhouses.
